In conclusion, our study demonstrated that PRR induces myocardial fibrosis and deteriorates cardiac function through ROS from the PRR-ERK1/2-NOX4 pathway during ACM development. The gene discussed is ATP6AP2; the disease is Myocardial fibrosis.